• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中的亚临床动脉粥样硬化性血管疾病:基于医院的前瞻性病例对照研究。

Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study.

作者信息

Chindhi Sandip, Thakur Surinder, Sarkar Malay, Negi Prakash C

机构信息

Department of General Medicine, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India.

Department of Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

出版信息

Lung India. 2015 Mar-Apr;32(2):137-41. doi: 10.4103/0970-2113.152624.

DOI:10.4103/0970-2113.152624
PMID:25814798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4372867/
Abstract

INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is an important non-communicable disease worldwide with a rising global incidence. COPD is associated with multiple co-morbidities. Patients with COPD are at increased risk of atherosclerosis and other cardiovascular events. Cardiovascular diseases are an important cause of morbidity and mortality in COPD. The present case-control study was designed to assess the relationship between sub-clinical atherosclerotic vascular diseases with COPD.

METHODS

It was a prospective case-control blinded observational study. There were 142 COPD patients and 124 age-and sex-matched controls without COPD and cardiovascular diseases. Frequency of sub-clinical atherosclerosis was assessed by the carotid B-mode duplex ultrasonography assessment of carotid wall intima medial thickness (IMT). Plaque was defined as IMT of more than 1.2 mm.

RESULTS

Prevalence of carotid plaqing was significantly higher amongst patients of COPD (38.7%) compared to controls (13.7%, odds ratio 3.9, P < 0.0001). Multinomial logistic regression analysis revealed COPD as an independent predictor of carotid plaqing (r = 0.85, P < 0.023).

CONCLUSION

The frequency of carotid plaqing is high in COPD patients. Carotid plaqing may be due to shared risk factors or the presence of low-grade systemic inflammation. Presence of increased CIMT and carotid plaqing in COPD patients identifies early atherosclerotic changes and future cardiovascular risk. Hence screening of CIMT should be a part of cardiovascular assessment in patients with COPD.

摘要

引言

慢性阻塞性肺疾病(COPD)是一种在全球范围内重要的非传染性疾病,其全球发病率呈上升趋势。COPD与多种合并症相关。COPD患者发生动脉粥样硬化和其他心血管事件的风险增加。心血管疾病是COPD发病和死亡的重要原因。本病例对照研究旨在评估亚临床动脉粥样硬化性血管疾病与COPD之间的关系。

方法

这是一项前瞻性病例对照双盲观察性研究。有142例COPD患者和124例年龄及性别匹配的无COPD和心血管疾病的对照者。通过颈动脉B型双功超声评估颈动脉壁内膜中层厚度(IMT)来评估亚临床动脉粥样硬化的频率。斑块定义为IMT大于1.2毫米。

结果

与对照组(13.7%)相比,COPD患者颈动脉斑块形成的患病率显著更高(38.7%,优势比3.9,P<0.0001)。多项逻辑回归分析显示COPD是颈动脉斑块形成的独立预测因素(r = 0.85,P<0.023)。

结论

COPD患者颈动脉斑块形成的频率较高。颈动脉斑块形成可能是由于共同的危险因素或存在低度全身炎症。COPD患者中CIMT增加和颈动脉斑块形成提示早期动脉粥样硬化改变和未来心血管风险。因此,对CIMT的筛查应成为COPD患者心血管评估的一部分。

相似文献

1
Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease: Prospective hospital-based case control study.慢性阻塞性肺疾病中的亚临床动脉粥样硬化性血管疾病:基于医院的前瞻性病例对照研究。
Lung India. 2015 Mar-Apr;32(2):137-41. doi: 10.4103/0970-2113.152624.
2
Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies.慢性阻塞性肺疾病患者的亚临床颈动脉粥样硬化:文献研究的荟萃分析
Ann Med. 2017 Sep;49(6):513-524. doi: 10.1080/07853890.2017.1311022. Epub 2017 Apr 17.
3
[Evaluation of carotis intima media thickness in chronic obstructive pulmonary disease patients].[慢性阻塞性肺疾病患者颈动脉内膜中层厚度的评估]
Tuberk Toraks. 2012;60(3):238-45. doi: 10.5578/tt.3779.
4
Association of COPD with carotid wall intima-media thickness in vascular surgery patients.血管外科患者 COPD 与颈动脉壁内中膜厚度的相关性。
Respir Med. 2010 May;104(5):712-6. doi: 10.1016/j.rmed.2009.10.027. Epub 2009 Nov 25.
5
Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.慢性阻塞性肺疾病(COPD)患者肱动脉内膜中层厚度增加与不对称二甲基精氨酸的循环水平相关。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 4;12:169-176. doi: 10.2147/COPD.S118596. eCollection 2017.
6
Carotid intima-media thickness in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的颈动脉内膜中层厚度
Bratisl Lek Listy. 2011;112(1):24-8.
7
Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.慢性阻塞性肺疾病患者的亚临床动脉粥样硬化风险标志物:一项系统评价和荟萃分析。
Respir Med. 2017 Feb;123:18-27. doi: 10.1016/j.rmed.2016.12.004. Epub 2016 Dec 8.
8
Subclinical Carotid Atherosclerosis in COPD Cases and Control Smokers: Analysis in Relation with COPD Exacerbations and Exacerbation-like Episodes.慢性阻塞性肺疾病患者与对照吸烟者的亚临床颈动脉粥样硬化:与慢性阻塞性肺疾病急性加重及类似急性加重发作的相关性分析
Lung. 2017 Apr;195(2):185-191. doi: 10.1007/s00408-017-9986-4. Epub 2017 Feb 24.
9
Carotid intima-media thickness in chronic obstructive pulmonary disease and survival: A multicenter prospective study.慢性阻塞性肺疾病中的颈动脉内膜中层厚度与生存率:一项多中心前瞻性研究。
Clin Respir J. 2019 Jun;13(6):391-399. doi: 10.1111/crj.13024. Epub 2019 May 8.
10
[Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].[系统性红斑狼疮患者颈动脉内膜中层增厚及动脉粥样硬化斑块形成的危险因素]
Ann Acad Med Stetin. 2008;54(2):22-32.

引用本文的文献

1
Pulmonary function test and carotid intima-media thickness in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺功能测试与颈动脉内膜中层厚度
Caspian J Intern Med. 2025 Jun 23;16(3):487-492. doi: 10.22088/cjim.16.3.487. eCollection 2025 Summer.
2
The Effects of Smoking and Airway Restriction on Subclinical Atherosclerosis.吸烟与气道受限对亚临床动脉粥样硬化的影响。
Int J Chron Obstruct Pulmon Dis. 2025 Apr 24;20:1217-1226. doi: 10.2147/COPD.S512381. eCollection 2025.
3
Evaluation of atherosclerosis as a risk factor in COPD patients by measuring the carotid intima-media thickness.评估颈动脉内膜中层厚度在 COPD 患者中的动脉粥样硬化作为危险因素的价值。
Cardiovasc Ultrasound. 2024 Jan 10;22(1):2. doi: 10.1186/s12947-023-00322-8.
4
Circadian clock-based therapeutics in chronic pulmonary diseases.基于生物钟的慢性肺部疾病治疗方法。
Trends Pharmacol Sci. 2022 Dec;43(12):1014-1029. doi: 10.1016/j.tips.2022.09.004. Epub 2022 Oct 24.
5
Serum levels of trace minerals and heavy metals in severe COPD patients with and without pulmonary hypertension.伴有和不伴有肺动脉高压的重度慢性阻塞性肺疾病患者的血清微量元素和重金属水平
Int J Chron Obstruct Pulmon Dis. 2018 May 31;13:1803-1808. doi: 10.2147/COPD.S164431. eCollection 2018.
6
Study of oxidative stress biomarkers in chronic obstructive pulmonary disease and their correlation with disease severity in north Indian population cohort.印度北部人群队列中慢性阻塞性肺疾病氧化应激生物标志物的研究及其与疾病严重程度的相关性
Lung India. 2017 Jul-Aug;34(4):324-329. doi: 10.4103/lungindia.lungindia_205_16.
7
Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中的全身及肺血管重塑
PLoS One. 2016 Apr 5;11(4):e0152987. doi: 10.1371/journal.pone.0152987. eCollection 2016.
8
Age and sex matching in case-control studies.病例对照研究中的年龄和性别匹配。
Lung India. 2015 Sep-Oct;32(5):544. doi: 10.4103/0970-2113.164149.

本文引用的文献

1
Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study.老年人慢性阻塞性肺疾病与脂质核心颈动脉斑块:鹿特丹研究。
Am J Respir Crit Care Med. 2013 Jan 1;187(1):58-64. doi: 10.1164/rccm.201206-1046OC. Epub 2012 Nov 9.
2
Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.慢性阻塞性肺疾病的肺外合并症:最新进展。
Expert Rev Respir Med. 2011 Oct;5(5):647-62. doi: 10.1586/ers.11.62.
3
Systemic manifestations of COPD.COPD 的全身表现。
Chest. 2011 Jan;139(1):165-73. doi: 10.1378/chest.10-1252.
4
Association of COPD with carotid wall intima-media thickness in vascular surgery patients.血管外科患者 COPD 与颈动脉壁内中膜厚度的相关性。
Respir Med. 2010 May;104(5):712-6. doi: 10.1016/j.rmed.2009.10.027. Epub 2009 Nov 25.
5
Future treatments for chronic obstructive pulmonary disease and its comorbidities.慢性阻塞性肺疾病及其合并症的未来治疗方法。
Proc Am Thorac Soc. 2008 Dec 1;5(8):857-64. doi: 10.1513/pats.200807-069TH.
6
The cytokine network in asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病中的细胞因子网络
J Clin Invest. 2008 Nov;118(11):3546-56. doi: 10.1172/JCI36130.
7
Airflow limitation in smokers is associated with subclinical atherosclerosis.吸烟者的气流受限与亚临床动脉粥样硬化有关。
Am J Respir Crit Care Med. 2009 Jan 1;179(1):35-40. doi: 10.1164/rccm.200804-560OC. Epub 2008 Oct 17.
8
Complex chronic comorbidities of COPD.慢性阻塞性肺疾病的复杂慢性合并症
Eur Respir J. 2008 Jan;31(1):204-12. doi: 10.1183/09031936.00114307.
9
The metabolic syndrome in South Asians: continuing escalation & possible solutions.南亚人群中的代谢综合征:持续升级与可能的解决方案。
Indian J Med Res. 2007 Mar;125(3):345-54.
10
Mortality in COPD: Role of comorbidities.慢性阻塞性肺疾病中的死亡率:合并症的作用。
Eur Respir J. 2006 Dec;28(6):1245-57. doi: 10.1183/09031936.00133805.